澳洋健康
(002172)
| 流通市值：41.55亿 | | | 总市值：41.58亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 822,546,484.46 | 406,693,952.2 | 1,806,837,366.11 | 1,360,398,182.64 |
| 营业总成本 | 795,003,665.61 | 396,403,863.58 | 1,744,055,248.13 | 1,305,911,354.22 |
| 其他经营收益 | | | | |
| 营业利润 | 32,520,435.52 | 8,355,988.33 | 64,359,106.35 | 56,199,607.73 |
| 利润总额 | 34,686,699.05 | 7,763,136.84 | 59,699,227.91 | 60,586,822.35 |
| 净利润 | 24,145,664.85 | 5,195,501.59 | 41,884,746.38 | 40,715,203.44 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 117,033.58 | - |
| 综合收益总额 | 24,145,664.85 | 5,195,501.59 | 42,001,779.96 | 40,715,203.44 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 954,221,438.93 | 893,952,318.63 | 935,092,311.33 | 1,055,512,613.01 |
| 非流动资产: | | | | |
| 非流动资产合计 | 832,910,367.15 | 844,163,256.57 | 854,426,892.07 | 873,329,143.33 |
| 资产总计 | 1,787,131,806.08 | 1,738,115,575.2 | 1,789,519,203.4 | 1,928,841,756.34 |
| 流动负债: | | | | |
| 流动负债合计 | 1,539,013,174.66 | 1,505,221,869.79 | 1,537,452,300.11 | 1,634,547,875.08 |
| 非流动负债: | | | | |
| 非流动负债合计 | 66,626,189.61 | 70,351,426.86 | 94,729,626.33 | 139,313,180.82 |
| 负债合计 | 1,605,639,364.27 | 1,575,573,296.65 | 1,632,181,926.44 | 1,773,861,055.9 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 200,095,482.97 | 181,166,852.46 | 175,930,797 | 174,636,111.86 |
| 股东权益合计 | 181,492,441.81 | 162,542,278.55 | 157,337,276.96 | 154,980,700.44 |
| 负债和股东权益合计 | 1,787,131,806.08 | 1,738,115,575.2 | 1,789,519,203.4 | 1,928,841,756.34 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 650,282,805.53 | 378,912,261.17 | 1,931,145,667.07 | 1,360,151,975.06 |
| 经营活动现金流出小计 | 700,052,902.11 | 347,077,183.13 | 1,918,525,282.79 | 1,388,807,398.37 |
| 经营活动产生的现金流量净额 | -49,770,096.58 | 31,835,078.04 | 12,620,384.28 | -28,655,423.31 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 64,330.73 | 1,066.18 | 252,358.23 | 39,422 |
| 投资活动现金流出小计 | 9,376,100.65 | 5,003,935.93 | 43,641,776 | 29,543,595.44 |
| 投资活动产生的现金流量净额 | -9,311,769.92 | -5,002,869.75 | -43,389,417.77 | -29,504,173.44 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 777,434,500 | 552,705,023.18 | 1,229,980,962.66 | 1,106,459,714.67 |
| 筹资活动现金流出小计 | 727,635,514.1 | 625,507,996.51 | 1,305,343,188.79 | 1,091,258,739.35 |
| 筹资活动产生的现金流量净额 | 49,798,985.9 | -72,802,973.33 | -75,362,226.13 | 15,200,975.32 |
| 汇率变动对现金及现金等价物的影响 | -9,607.93 | -15,027.83 | -21,923.16 | -8,607.45 |
| 现金及现金等价物净增加额 | -9,292,488.53 | -45,985,792.87 | -106,153,182.78 | -42,967,228.88 |
| 期末现金及现金等价物余额 | 150,621,122.83 | 113,927,818.49 | 159,913,611.36 | 223,099,565.26 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -9,292,488.53 | - | -106,153,182.78 | - |